Literature DB >> 8173920

Results of major hepatectomy for large primary liver cancer in patients with cirrhosis.

L Capussotti1, G Borgonovo, H Bouzari, C Smadja, D Grange, D Franco.   

Abstract

Major hepatectomy is associated with a high operative risk in patients with cirrhosis. Between June 1983 and December 1991, 33 cirrhotic patients, 31 with good liver function, underwent major liver resection for a large hepatic primary cancer. The hospital mortality rate was 3 per cent; the only death resulted from liver failure after extended right hepatectomy. None of the patients had variceal bleeding during the postoperative period. Survival rates at 1, 2 and 3 years were 66, 43 and 37 per cent respectively. Recurrence was the most common reason for late death. These results suggest that the operative risk of major hepatectomy in cirrhotic patients with a large tumour and good liver function is comparable to that of minor liver resection. Late survival is also similar to that of patients with a small tumour. Cirrhotic patients with hepatic carcinoma and good liver function are suitable for major hepatectomy.

Entities:  

Mesh:

Year:  1994        PMID: 8173920     DOI: 10.1002/bjs.1800810335

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 2.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

3.  Feasibility of the Glissonian approach during right hepatectomy.

Authors:  Charlotte Mouly; David Fuks; François Browet; François Mauvais; Arnaud Potier; Thierry Yzet; Qassemyar Quentin; Jean-Marc Regimbeau
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

4.  Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk.

Authors:  Alban Zarzavadjian Le Bian; Renato Costi; Vassilis Constantinides; Claude Smadja
Journal:  J Gastrointest Surg       Date:  2012-10-09       Impact factor: 3.452

5.  Updates and Critical Insights on Glissonian Approach in Liver Surgery.

Authors:  Demetrios Moris; Amir A Rahnemai-Azar; Diamantis I Tsilimigras; Ioannis Ntanasis-Stathopoulos; Hugo P Marques; Eleftherios Spartalis; Evangelos Felekouras; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-11-03       Impact factor: 3.452

6.  Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

7.  Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas.

Authors:  Dongil Choi; Hyo K Lim; Hyunchul Rhim
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 8.  Current opinion on the role of resection and liver transplantation for hepatocellular cancer.

Authors:  P Puneet; M T P R Perera; Darius F Mirza
Journal:  Indian J Gastroenterol       Date:  2012-06-19

9.  Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

Authors:  Chin-Ta Lin; Kuo-Feng Hsu; Teng-Wei Chen; Jyh-Cherng Yu; De-Chuan Chan; Chih-Yung Yu; Tsai-Yuan Hsieh; Hsiu-Lung Fan; Shih-Ming Kuo; Kuo-Piao Chung; Chung-Bao Hsieh
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

10.  Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.

Authors:  H Eguchi; K Umeshita; M Sakon; H Nagano; Y Ito; S I Kishimoto; K Dono; S Nakamori; T Takeda; M Gotoh; K Wakasa; N Matsuura; M Monden
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.